//
Zaenab Dhari - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Central Nervous System (CNS)
Multiple Sclerosis
N/A
Lars Costers - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Ralph H.B. Benedict - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Susanne Clinch - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2021
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Trishna Bharadia - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Central Nervous System (CNS)
Multiple Sclerosis
N/A
Whitney N Neal - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2021
Therapeutic Area
Disease
Drug/Treatment
Central Nervous System (CNS)
Multiple Sclerosis
N/A
S. Erridge - International Hepato-Pancreato-Biliary Association (IHPBA) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Liver cancer
N/A
M. Papoulas - International Hepato-Pancreato-Biliary Association (IHPBA) , 2017
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
H. Abbas - International Hepato-Pancreato-Biliary Association (IHPBA) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Secondary liver cancer
N/A
A.B. Fajardo-Puerta - International Hepato-Pancreato-Biliary Association (IHPBA) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Intraductal papillary mucinous neoplasm
N/A
S. Erridge - International Hepato-Pancreato-Biliary Association (IHPBA) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Breast cancer
N/A
R. Fichtinger - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
B. Gorgec - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
D.A. Raptis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
N. Rashidian - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
C.A. Chew - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Colorectal liver metastases
N/A
S. Shankar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
B.V. Dasari - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Colorectal liver metastases
N/A
G. Gemenetzis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Pancreato-biliary malignancies
N/A
L. Jones - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A